Published in Neuroscience on February 01, 1987
Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol (1992) 1.95
Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res (1991) 1.90
Febrile seizures and mechanisms of epileptogenesis: insights from an animal model. Adv Exp Med Biol (2004) 1.02
Neuropsychological Functions of μ- and δ-Opioid Systems. ISRN Addict (2013) 0.75
Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (1999) 6.37
PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron (2000) 2.56
Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res (1983) 2.46
Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med (2000) 2.34
Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse (1989) 2.23
Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia (1994) 2.05
Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A (2001) 1.88
Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature (1993) 1.81
Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res (1984) 1.59
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci (1989) 1.57
Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia (1992) 1.57
The role of GSK-3 in synaptic plasticity. Br J Pharmacol (2008) 1.52
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis. Acta Neurol Scand (2003) 1.51
Glutamate: a new target in schizophrenia? Trends Pharmacol Sci (1990) 1.43
New insights from the use of pilocarpine and kainate models. Epilepsy Res (2002) 1.42
Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia (1999) 1.39
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP. Neuron (2001) 1.27
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology (1998) 1.25
Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci U S A (2000) 1.21
The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Brain Res (1987) 1.20
N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A (1999) 1.20
Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp Brain Res (1995) 1.18
Cholinomimetics produce seizures and brain damage in rats. Experientia (1983) 1.18
NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann Neurol (1990) 1.11
Developmental aspects of the pilocarpine model of epilepsy. Epilepsy Res (1996) 1.10
Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci Biobehav Rev (1990) 1.10
Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroencephalogr Clin Neurophysiol (1982) 1.09
Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res (1995) 1.07
Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons. Cell Death Differ (2004) 1.05
Antiepileptic drugs and the developing brain. Cell Mol Life Sci (2006) 1.04
The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Res (1999) 1.03
The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. Pol J Pharmacol Pharm (1989) 1.02
Synaptic activation of a presynaptic kainate receptor facilitates AMPA receptor-mediated synaptic transmission at hippocampal mossy fibre synapses. Neuropharmacology (2001) 1.02
Alprazolam dependence prevented by substituting with the beta-carboline abecarnil. Proc Natl Acad Sci U S A (1997) 1.01
In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(D)-aspartic acid agonist, in the mammalian striatum. J Neurosci (1986) 1.00
Age-related changes in kynurenic acid production in rat brain. Brain Res (1992) 1.00
Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci U S A (1993) 1.00
A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices. Br J Pharmacol (2000) 0.99
Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience (1986) 0.99
Effect of physical exercise on seizure occurrence in a model of temporal lobe epilepsy in rats. Epilepsy Res (1999) 0.98
Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids (2008) 0.96
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. Neuroreport (1996) 0.96
The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys. Ann Neurol (1991) 0.94
Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther (1990) 0.94
Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia (1994) 0.93
Muscle relaxant action of excitatory amino acid antagonists. Neurosci Lett (1985) 0.92
Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats. Epilepsy Res (2001) 0.92
Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res (1987) 0.92
Lack of Fos-like immunoreactivity after spontaneous seizures or reinduction of status epilepticus by pilocarpine in rats. Neurosci Lett (1996) 0.92
Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. J Pharmacol Exp Ther (1993) 0.91
Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem (1997) 0.91
Mitogen-activated protein kinase is increased in the limbic structures of the rat brain during the early stages of status epilepticus. Brain Res Bull (1998) 0.90
Excitotoxicity and neurodegenerative diseases. Curr Opin Neurol (1995) 0.90
Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc Natl Acad Sci U S A (1987) 0.89
Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients. Hepat Res Treat (2013) 0.89
Neuropeptide-Y immunoreactivity in the pilocarpine model of temporal lobe epilepsy. Exp Brain Res (1997) 0.89
Morphological and electrophysiological properties of pyramidal-like neurons in the stratum oriens of Cornu ammonis 1 and Cornu ammonis 2 area of Proechimys. Neuroscience (2011) 0.88
Effect of physical exercise on kindling development. Epilepsy Res (1998) 0.88
Glycosaminoglycan levels and proteoglycan expression are altered in the hippocampus of patients with mesial temporal lobe epilepsy. Brain Res Bull (2002) 0.88
Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Res (1986) 0.87
AMPA and GABA(B) receptor antagonists and their interaction in rats with a genetic form of absence epilepsy. Eur J Pharmacol (2001) 0.87
Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation. Psychopharmacol Ser (1993) 0.87
Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. Proc Natl Acad Sci U S A (1996) 0.86
Susceptibility to seizures produced by pilocarpine in rats after microinjection of isoniazid or gamma-vinyl-GABA into the substantia nigra. Brain Res (1986) 0.86
Substantia nigra: a site of action of muscle relaxant drugs. Ann Neurol (1990) 0.86
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. J Neural Transm Park Dis Dement Sect (1991) 0.85
Long-term treatment with abecarnil does not induce diazepam-like dependence in mice. J Pharmacol Exp Ther (1993) 0.84
Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: an electroencephalographic, behavioural and morphological analysis. Neuroscience (1985) 0.84
Hormonal and gestational parameters in female rats submitted to the pilocarpine model of epilepsy. Epilepsy Res (1998) 0.84
Neurodegenerative disorders: clues from glutamate and energy metabolism. Crit Rev Neurobiol (1996) 0.84